ETF Building Blocks ChannelConsolidation Could Come Calling for Biotech in 2022By Tom LydonJanuary 5, 2022
Innovative ETFs ChannelModerna’s Omicron Booster Strategy Lifts Biotechnology ETFsBy Max ChenNovember 29, 2021
ETF Building Blocks ChannelMemeification of Biotech Stocks Shines Light on This ETFBy Tom LydonNovember 24, 2021
Innovative ETFs ChannelPfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFsBy Max ChenNovember 5, 2021
ETF Building Blocks ChannelBiotech Ready to Participate in Healthcare BullishnessBy Tom LydonOctober 29, 2021
ETF Building Blocks ChannelDrug Price Debate May Not Hinder Biotech ETFs After AllBy Tom LydonSeptember 16, 2021